Global Blood Therapeutics, Inc. announced that Ted W. Love, M.D., Scott W. Morison, Deval L. Patrick, Mark L. Perry, Glenn F. Pierce, M.D., Ph.D., Philip A. Pizzo, M.D., Dawn A. Svoronos, Alexis A. Thompson, M.D., M.P.H., and Wendy L. Yarno resigned from the board of directors of GBT. At the Effective Time, Deborah Baron and Andrew J. Muratore, each a director of Merger Sub immediately prior to the Effective Time, became directors of GBT. In addition, Dr. Love ceased to be the President and Chief Executive Officer of the Company, effective as of the Closing Date.